| Dr Paul E Gerard Iii, MD | |
|
100 Helmwood Plaza Dr, Elizabethtown, KY 42701-2975 | |
| (270) 769-5579 | |
| (270) 765-7975 |
| Full Name | Dr Paul E Gerard Iii |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 50 Years |
| Location | 100 Helmwood Plaza Dr, Elizabethtown, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154327385 | NPI | - | NPPES |
| 64180961 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 18096 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hardin Memorial Hospital | Elizabethtown, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Baptist Health Medical Group Inc | 5597867184 | 1912 |
News Archive
More than a thousand years ago, somewhere in Southeast Asia, a fateful meeting occurred between a mosquito-borne virus that infected mainly monkeys and a large, susceptible group of humans.
Three out of five women who have given birth to a child with a congenital heart defect (CHD) - the number-one birth defect and leading killer of infants and newborns - were never tested for the defect during pregnancy. This is according to a survey just released by Little Hearts, Inc., a national organization that provides support, education, resources, networking and hope to families affected by congenital heart defects.
Pfizer Inc. today announced that the U.S. Food and Drug Administration approved MYLOTARG (gemtuzumab ozogamicin) for adults with newly diagnosed CD33-positive acute myeloid leukemia (AML), and adults and children 2 years and older with relapsed or refractory CD33-positive AML.
At a press conference featuring healthcare leaders from throughout the state, Governor Donald L. Carcieri will announce that Rhode Island has launched a new system for tracking swine flu. Unprecedented in its approach, the system makes use of prescribing data provided by pharmacies throughout the state via a secure electronic link. In yet another first for the state and the nation, Rhode Island will also announce that it has now connected 100 percent of its retail pharmacies for e-prescribing.
3M Health Care today announced the introduction of a full line of new, innovative Tegaderm™ High Performance Foam Adhesive Dressings. In clinical and laboratory tests, these new adhesive foam wound dressings outperform other leading foam adhesive dressings in managing the full range of low- to high-moisture conditions that can be present in chronic and acute wounds.
› Verified 9 days ago
| Entity Name | Hardin Professional Services, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306894704 PECOS PAC ID: 9739191628 Enrollment ID: O20060614000061 |
News Archive
More than a thousand years ago, somewhere in Southeast Asia, a fateful meeting occurred between a mosquito-borne virus that infected mainly monkeys and a large, susceptible group of humans.
Three out of five women who have given birth to a child with a congenital heart defect (CHD) - the number-one birth defect and leading killer of infants and newborns - were never tested for the defect during pregnancy. This is according to a survey just released by Little Hearts, Inc., a national organization that provides support, education, resources, networking and hope to families affected by congenital heart defects.
Pfizer Inc. today announced that the U.S. Food and Drug Administration approved MYLOTARG (gemtuzumab ozogamicin) for adults with newly diagnosed CD33-positive acute myeloid leukemia (AML), and adults and children 2 years and older with relapsed or refractory CD33-positive AML.
At a press conference featuring healthcare leaders from throughout the state, Governor Donald L. Carcieri will announce that Rhode Island has launched a new system for tracking swine flu. Unprecedented in its approach, the system makes use of prescribing data provided by pharmacies throughout the state via a secure electronic link. In yet another first for the state and the nation, Rhode Island will also announce that it has now connected 100 percent of its retail pharmacies for e-prescribing.
3M Health Care today announced the introduction of a full line of new, innovative Tegaderm™ High Performance Foam Adhesive Dressings. In clinical and laboratory tests, these new adhesive foam wound dressings outperform other leading foam adhesive dressings in managing the full range of low- to high-moisture conditions that can be present in chronic and acute wounds.
› Verified 9 days ago
| Entity Name | Baptist Health Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922401611 PECOS PAC ID: 5597867184 Enrollment ID: O20150219000942 |
News Archive
More than a thousand years ago, somewhere in Southeast Asia, a fateful meeting occurred between a mosquito-borne virus that infected mainly monkeys and a large, susceptible group of humans.
Three out of five women who have given birth to a child with a congenital heart defect (CHD) - the number-one birth defect and leading killer of infants and newborns - were never tested for the defect during pregnancy. This is according to a survey just released by Little Hearts, Inc., a national organization that provides support, education, resources, networking and hope to families affected by congenital heart defects.
Pfizer Inc. today announced that the U.S. Food and Drug Administration approved MYLOTARG (gemtuzumab ozogamicin) for adults with newly diagnosed CD33-positive acute myeloid leukemia (AML), and adults and children 2 years and older with relapsed or refractory CD33-positive AML.
At a press conference featuring healthcare leaders from throughout the state, Governor Donald L. Carcieri will announce that Rhode Island has launched a new system for tracking swine flu. Unprecedented in its approach, the system makes use of prescribing data provided by pharmacies throughout the state via a secure electronic link. In yet another first for the state and the nation, Rhode Island will also announce that it has now connected 100 percent of its retail pharmacies for e-prescribing.
3M Health Care today announced the introduction of a full line of new, innovative Tegaderm™ High Performance Foam Adhesive Dressings. In clinical and laboratory tests, these new adhesive foam wound dressings outperform other leading foam adhesive dressings in managing the full range of low- to high-moisture conditions that can be present in chronic and acute wounds.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Paul E Gerard Iii, MD 100 Helmwood Plaza Dr, Elizabethtown, KY 42701-2975 Ph: (270) 769-5579 | Dr Paul E Gerard Iii, MD 100 Helmwood Plaza Dr, Elizabethtown, KY 42701-2975 Ph: (270) 769-5579 |
News Archive
More than a thousand years ago, somewhere in Southeast Asia, a fateful meeting occurred between a mosquito-borne virus that infected mainly monkeys and a large, susceptible group of humans.
Three out of five women who have given birth to a child with a congenital heart defect (CHD) - the number-one birth defect and leading killer of infants and newborns - were never tested for the defect during pregnancy. This is according to a survey just released by Little Hearts, Inc., a national organization that provides support, education, resources, networking and hope to families affected by congenital heart defects.
Pfizer Inc. today announced that the U.S. Food and Drug Administration approved MYLOTARG (gemtuzumab ozogamicin) for adults with newly diagnosed CD33-positive acute myeloid leukemia (AML), and adults and children 2 years and older with relapsed or refractory CD33-positive AML.
At a press conference featuring healthcare leaders from throughout the state, Governor Donald L. Carcieri will announce that Rhode Island has launched a new system for tracking swine flu. Unprecedented in its approach, the system makes use of prescribing data provided by pharmacies throughout the state via a secure electronic link. In yet another first for the state and the nation, Rhode Island will also announce that it has now connected 100 percent of its retail pharmacies for e-prescribing.
3M Health Care today announced the introduction of a full line of new, innovative Tegaderm™ High Performance Foam Adhesive Dressings. In clinical and laboratory tests, these new adhesive foam wound dressings outperform other leading foam adhesive dressings in managing the full range of low- to high-moisture conditions that can be present in chronic and acute wounds.
› Verified 9 days ago
Dr. Yasir Saifullah, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 103 Financial Pl Ste 100, Elizabethtown, KY 42701 Phone: 270-769-0110 Fax: 270-765-6953 | |
Dr. Jahin Patel, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2411 Ring Rd Ste 114, Elizabethtown, KY 42701 Phone: 270-706-1925 Fax: 270-706-1926 | |
Mujahid A Nasir, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1311 Ring Rd, Ste 101, Elizabethtown, KY 42701 Phone: 270-900-4555 Fax: 270-900-4636 | |
Dr. Samuel Phillip Pike, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 100 Helmwood Plaza Drive, Elizabethtown, KY 42701 Phone: 270-765-6242 Fax: 270-765-6243 | |
Kyle A Romines, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2413 Ring Rd Ste 100, Elizabethtown, KY 42701 Phone: 270-737-0077 Fax: 270-706-5549 | |
David J. Zoeller, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2413 Ring Rd Ste 110, Elizabethtown, KY 42701 Phone: 270-765-4535 Fax: 270-763-1901 |